Abstract
Objective To determine if losing work during the COVID-19 pandemic is associated with mental and physical health. To determine if social interactions and financial resources moderate the relationship between work loss and health.
Design Baseline data from a prospective longitudinal cohort study.
Setting Australia, 27th March to 12th June 2020.
Participants Australians aged 18+ years, employed in a paid job prior to the COVID-19 pandemic who responded to an online or telephone survey.
Main Outcome Measures Kessler-6 score > 18 indicating high psychological distress. Short Form 12 (SF-12) mental health or physical health component score < = 45 indicating poor mental or physical health.
Results 2,603 respondents including groups who had lost their job (N = 541), were not working but remained employed (N = 613), were working less (N = 789) and whose work was unaffected (N = 789). Three groups experiencing work loss had greater odds of high psychological distress (AOR = 2.22–3.66), poor mental (AOR = 1.78–2.27) and physical health (AOR = 2.10–2.12) than the unaffected work group. Poor mental health was more common than poor physical health. The odds of high psychological distress (AOR = 5.43–8.36), poor mental (AOR = 1.92–4.53) and physical health (AOR = 1.93–3.90) were increased in those reporting fewer social interactions or less financial resources.
Conclusion Losing work during the COVID-19 pandemic is associated with mental and physical health problems, and this relationship is moderated by social interactions and financial resources. Responses that increase financial security and enhance social connections may partially alleviate the health impacts of work loss.
Registration Australian New Zealand Clinical Trials Registry: ACTRN12620000857909.
Competing Interest Statement
Funding was provided by Monash University and the icare Foundation. The views expressed are those of the authors and may not reflect the views of study funders.
Clinical Trial
Australian New Zealand Clinical Trials Registry: ACTRN12620000857909
Funding Statement
Funding was provided by Monash University and the icare Foundation. The views expressed are those of the authors and may not reflect the views of study funders. Professor Alex Collie is supported by an ARC Future Fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval to conduct the study was provided by Monash University Human Research Ethics Committee.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.